Millennium Management
MBX

Millennium Management’s MBX Biosciences MBX Stock Holding History

Millennium Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,000
Closed -$438K – 6570
2025
Q3 		$438K Sell
25,000
-26,300
-51% -$352K ﹤0.01% 5153
2025
Q2 		$585K Buy
+51,300
New +$523K ﹤0.01% 4797

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management's MBX Position: Q1 2026 in Review

Millennium Management increased its MBX Biosciences (MBX) stake by 22% in Q1 2026, buying an estimated $3.48M and bringing the position to 564,415 shares worth $16.8M. The position accounts for 0.01% of the portfolio, ranked #1691.

Millennium Management first reported a position in MBX in Q3 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Millennium Management held 564,415 shares of MBX Biosciences worth $16.8M as of Q1 2026.
  • Millennium Management bought 102,366 MBX Biosciences shares in Q1 2026, an estimated $3.48M.
  • MBX Biosciences made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1691 holding.
  • Millennium Management first reported a position in MBX Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.